Search results for SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael

Explore all categories to find your favorite topic

The Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS) M. Valgimigli, MD, PhD Erasmus MC, Rotterdam The Netherlands On behalf of the ZEUS Investigators…

P M J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L 4 N O 6 2 0 1 1 © 2 0 1 1 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U…

Slide 1 ISAR-TEST 5: Randomized, Non-inferiority Trial of Rapamycin/Probucol- and Zotarolimus-Eluting Stents J. Mehilli, MD A. Kastrati, R.A. Byrne, S. Massberg, K. Tiroch,…

Supralimus™ bioabsorbable-polymer sirolimus-eluting stent technology in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Initial results…

Summary of Safety and Effectiveness Data I. General Information Product Generic Name: Drug-Eluting Coronary Stent System NIQ Product Trade Name: CYPHER™ Sirolimus-eluting…

Preoperative Cardiac Preoperative Cardiac StentsStents Perioperative Perioperative ManagementManagement Mark A Taylor MDMark A Taylor MD Department of AnesthesiaDepartment…

�������� �� ��� �� Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents…

J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . - , N O . - , 2 0 1 7 ª 2 0 1 7 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F…

Slide 1 Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000…

Endeavor Safety: Pooled Analysis of Early and Late Safety of a Zotarolimus-Eluting Stent Laura Mauri, MD, MSc Brigham and Women’s Hospital Harvard Clinical Research Institute…

LETTER TO THE EDITORKorean J Intern Med 2013;28:108-111http://dx.doi.org/10.3904/kjim.2013.28.1.108Copyright 2013 The Korean Association of Internal MedicineThis is an Open…

Prospective Randomized Trial of Paclitaxel- versus Sirolimus- Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents Robert A Byrne Julinda Mehilli…

__________ (acronym) TrialEvaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation Masamichi Takano,

Slide 1Infrapopliteal Sirolimus-Eluting Versus Bare Metal Stents for Critical Limb Ischemia: Long-Term Angiographic and Clinical Outcome in >100 Patients Dimitris Karnabatidis,…

AMPHILIMUSTM (SIROLIMUS+FATTY ACID) ELUTING CORONARY STENT E V O L V I N G P R O F I C I E N C YE V O L V I N G P R O F I C I E N C Y Abluminal Reservoir Technology The only…

Journal of the American College of Cardiology Vol. 57, No. 13, 2011 © 2011 by the American College of Cardiology Foundation ISSN 0735-1097$36.00 CLINICAL RESEARCH Interventional…

Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare Metal Stents in Diseased Saphenous Vein Grafts: Results from the Randomized DELAYED RRISC Trial Pierfrancesco…

Instructions for Use ENDEAVOR® Zotarolimus-Eluting Coronary Stent System Over-the-Wire Delivery System Caution: Federal (USA) law restricts this product to sale by or on…

A P S J Y K A O a ( B t f M A t a R t e m 7 n 7 C c d p C F M J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 1 , N O . 3 , 2 0 0 8 © 2 0 0 8 B Y…

Combo - A Combination Sirolimus Eluting Anti-CD34 Antibody Coated Stent: Technology Development Combo - A Combination Sirolimus Eluting Anti-CD34 Antibody Coated Stent: Technology…